Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE).

NCT02849522 is registered in ClinicalTrials.gov with Cedar, United Kingdom as lead sponsor.

NCT NCT02849522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02849522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE).
Lead sponsor
Cedar, United Kingdom
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2014
Completion date
September 30, 2017
Enrollment
300 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

laser enucleation or ablation of the prostate, lower urinary tract symptoms caused by benign prostatic enlargement (luts bpe), open prostatectomy, prostate artery embolisation (pae), transurethral resection of the prostate (turp)